Patents by Inventor Fabien Ribes

Fabien Ribes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130244956
    Abstract: The present invention relates to a novel compound of use in the improved delivery of therapeutic drug agents into target cells or tissues, composition comprising the same and uses thereof. The compound is more specifically a conjugate of a peptidic moiety and a camptothecin, a derivative or analog thereof which provides numerous benefits, including enhancement in terms of aqueous solubility, pharmacokinetics and tissue distribution, enlargement of the therapeutic index, and limitation of the inter-patient metabolic variability, as well as improvement of delivery of the biologically active ingredient to the target cells or tissues.
    Type: Application
    Filed: February 28, 2013
    Publication date: September 19, 2013
    Applicant: DRAIS PHARMACEUTICALS, INC.
    Inventors: Matthieu Michel, Denis Ravel, Fabien Ribes, Isabelle Tranchant
  • Patent number: 8410045
    Abstract: The present invention relates to a novel compound of use in the improved delivery of therapeutic drug agents into target cells or tissues, composition comprising the same and uses thereof. The compound is more specifically a conjugate of a peptide moiety and a camptothecin, a derivative or analog thereof which provides numerous benefits, including enhancement in terms of aqueous solubility, pharmacokinetics and tissue distribution, enlargement of the therapeutic index, and limitation of the inter-patient metabolic variability, as well as improvement of delivery of the biologically active ingredient to the target cells or tissues.
    Type: Grant
    Filed: March 30, 2007
    Date of Patent: April 2, 2013
    Assignee: Drais Pharmaceuticals, Inc.
    Inventors: Matthieu Michel, Denis Ravel, Fabien Ribes, Isabelle Tranchant
  • Publication number: 20100015136
    Abstract: The present invention relates to a novel compound of use in the improved delivery of therapeutic drug agents into target cells or tissues, composition comprising the same and uses thereof. The compound is more specifically a conjugate of a peptide moiety and a camptothecin, a derivative or analog thereof which provides numerous benefits, including enhancement in terms of aqueous solubility, pharmacokinetics and tissue distribution, enlargement of the therapeutic index, and limitation of the inter-patient metabolic variability, as well as improvement of delivery of the biologically active ingredient to the target cells or tissues.
    Type: Application
    Filed: March 30, 2007
    Publication date: January 21, 2010
    Applicant: DIATOS, S.A.
    Inventors: Matthieu Michel, Denis Ravel, Fabien Ribes, Isabelle Tranchant